M L Ancelin

Summary

Country: France

Publications

  1. ncbi request reprint [Hormonal replacement therapy and Alzheimer's disease. All quiet on the western front?]
    Marie Laure Ancelin
    Inserm E 361, Hôpital La Colombière, Montpellier
    Psychol Neuropsychiatr Vieil 1:251-7. 2003
  2. ncbi request reprint Lifelong endocrine fluctuations and related cognitive disorders
    M L Ancelin
    INSERM, E361, Montpellier, F 34093 France
    Curr Pharm Des 11:4229-52. 2005
  3. ncbi request reprint Hormonal therapy and depression: are we overlooking an important therapeutic alternative?
    Marie Laure Ancelin
    INSERM, U888, Montpellier, France
    J Psychosom Res 62:473-85. 2007
  4. pmc Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression
    M L Ancelin
    1 INSERM, U1061, Montpellier, France 2 Univ Montpellier 1, Montpellier, France
    Transl Psychiatry 3:e322. 2013
  5. ncbi request reprint [The Esprit Project: a longitudinal general population study of psychiatric disorders in France in subjects over 65 years old]
    M L Ancelin
    INSERM, E361, Montpellier, F 34093 France, Univ Montpellier 1, Montpellier, F 34000 France
    Encephale 32:S615-21. 2006
  6. pmc Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study
    J Ryan
    INSERM U888, Nervous System Pathologies Epidemiological and Clinical Research, Hôpital La Colombière, BP 34493, 34093 Montpellier Cedex 5, France
    Neurology 73:1729-37. 2009
  7. ncbi request reprint Prevalence of DSM-IV psychiatric disorder in the French elderly population
    K Ritchie
    Institut National de la Sante et de la Recherche Medicale INSERM, E 0361 Pathologies of the Nervous System, Montpellier, France
    Br J Psychiatry 184:147-52. 2004
  8. ncbi request reprint The neuroprotective effects of caffeine: a prospective population study (the Three City Study)
    K Ritchie
    INSERM U888 Nervous System Pathologies, Epidemiological and Clinical Research, La Colombière Hospital, Montpellier, France
    Neurology 69:536-45. 2007
  9. pmc A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people
    I Beluche
    INSERM, U888, University of Montpellier 1, Montpellier, France
    Psychol Med 40:1039-49. 2010
  10. doi request reprint Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents
    A M Dupuy
    INSERM U888, Montpellier, France
    Climacteric 11:74-83. 2008

Detail Information

Publications15

  1. ncbi request reprint [Hormonal replacement therapy and Alzheimer's disease. All quiet on the western front?]
    Marie Laure Ancelin
    Inserm E 361, Hôpital La Colombière, Montpellier
    Psychol Neuropsychiatr Vieil 1:251-7. 2003
    ..g. estradiol [transdermal] + progesterone). On the basis of the data of the literature, there is currently no reason to propose HRT for the prevention of Alzheimer's disease...
  2. ncbi request reprint Lifelong endocrine fluctuations and related cognitive disorders
    M L Ancelin
    INSERM, E361, Montpellier, F 34093 France
    Curr Pharm Des 11:4229-52. 2005
    ....
  3. ncbi request reprint Hormonal therapy and depression: are we overlooking an important therapeutic alternative?
    Marie Laure Ancelin
    INSERM, U888, Montpellier, France
    J Psychosom Res 62:473-85. 2007
    ..This review aimed to examine evidence for the role of hormonal changes in the onset and course of depressive symptomatology and to assess the possible future role of hormonal therapies in the treatment of depression...
  4. pmc Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression
    M L Ancelin
    1 INSERM, U1061, Montpellier, France 2 Univ Montpellier 1, Montpellier, France
    Transl Psychiatry 3:e322. 2013
    ..Whether this could represent a common pathophysiological mechanism linking HPA axis and late-life depression remains to be explored...
  5. ncbi request reprint [The Esprit Project: a longitudinal general population study of psychiatric disorders in France in subjects over 65 years old]
    M L Ancelin
    INSERM, E361, Montpellier, F 34093 France, Univ Montpellier 1, Montpellier, F 34000 France
    Encephale 32:S615-21. 2006
  6. pmc Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study
    J Ryan
    INSERM U888, Nervous System Pathologies Epidemiological and Clinical Research, Hôpital La Colombière, BP 34493, 34093 Montpellier Cedex 5, France
    Neurology 73:1729-37. 2009
    ..To examine the association between hormone therapy (HT) and cognitive performance or dementia, focusing on the duration and type of treatment used, as well as the timing of initiation of HT in relation to the menopause...
  7. ncbi request reprint Prevalence of DSM-IV psychiatric disorder in the French elderly population
    K Ritchie
    Institut National de la Sante et de la Recherche Medicale INSERM, E 0361 Pathologies of the Nervous System, Montpellier, France
    Br J Psychiatry 184:147-52. 2004
    ..France has high rates of psychotropic drug consumption and suicide in the elderly population, but it has not yet been possible to determine whether this is due to exceptionally high morbidity rates...
  8. ncbi request reprint The neuroprotective effects of caffeine: a prospective population study (the Three City Study)
    K Ritchie
    INSERM U888 Nervous System Pathologies, Epidemiological and Clinical Research, La Colombière Hospital, Montpellier, France
    Neurology 69:536-45. 2007
    ..To examine the association between caffeine intake, cognitive decline, and incident dementia in a community-based sample of subjects aged 65 years and over...
  9. pmc A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people
    I Beluche
    INSERM, U888, University of Montpellier 1, Montpellier, France
    Psychol Med 40:1039-49. 2010
    ..However, the causal relationship between stress and subsequent cognitive impairment remains unclear, notably because of the small number of gender-stratified prospective studies...
  10. doi request reprint Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents
    A M Dupuy
    INSERM U888, Montpellier, France
    Climacteric 11:74-83. 2008
    ..To evaluate plasma lipid levels in elderly women in the general population as a function of use of lipid-lowering agents (LLA) and hormone therapy (HT)...
  11. pmc Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors
    K Ritchie
    INSERM, U888 Nervous System Pathologies Epidemiological and Clinical Research, La Colombière Hospital, 34093 Montpellier Cedex 5, France
    BMJ 341:c3885. 2010
    ..To estimate the percentage reduction in incidence of dementia that would be obtained if specific risk factors were eliminated...
  12. ncbi request reprint The association between caffeine and cognitive decline: examining alternative causal hypotheses
    K Ritchie
    INSERM, Montpellier, France
    Int Psychogeriatr 26:581-90. 2014
    ..The assumed effect is that of reduced amyloid deposition, however, alternative pathways notably by reducing depression and diabetes type 2 risk have not been considered...
  13. pmc Hormonal treatment, mild cognitive impairment and Alzheimer's disease
    Joanne Ryan
    INSERM, U888, Montpellier, F 34093 France
    Int Psychogeriatr 20:47-56. 2008
    ....
  14. doi request reprint Late-life depression and mortality: influence of gender and antidepressant use
    Joanne Ryan
    Institut National de la Santé et de la Recherche Médicale Inserm U888, University of Montpellier, France
    Br J Psychiatry 192:12-8. 2008
    ..Depression may increase the risk of mortality among certain subgroups of older people, but the part played by antidepressants in this association has not been thoroughly explored...
  15. ncbi request reprint Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence
    Marie Laure Ancelin
    INSERM, U888, University of Montpellier 1, Montpellier, France
    Dement Geriatr Cogn Disord 24:1-19. 2007
    ....